← Russell 3000 cross-section

CON Concentra Group Holdings Parent, Inc.

Trailing twelve months to 2026-06-30 · as filed 2026-08-06, not restated
Healthcare

Scale

Market cap
$4.4bn
Revenue TTM
$2.3bn
Net income TTM
$199m
Free cash flow
$267m
Composite score
77.7
Sector rank
#1157

Valuation

P / E
22.3
EV / EBITDA
EV / sales
1.9
FCF yield
6.04%
Earnings yield vs 10-yr
-0.24pp

Earnings yield vs 10-yr compares what the business earns per pound invested against the 4.73% a 10-year US Treasury note pays for no equity risk. Negative means you are paying up front for growth not yet delivered.

Quality and growth

Net margin
8.7%
EBITDA margin
ROE
41.6%
ROIC
117.5%
Revenue growth

Insider activity, last 90 days

Net open-market
$-11.35m
Buyers
0
Sellers
1

Open-market purchases and sales only. Grants, option exercises, gifts and shares withheld for tax are excluded: they are how people are paid, not what they think.

What management said

Three Months Ended June 30, 2026, Compared to Three Months Ended June 30, 2025 Revenue Revenue increased 10.0% to $606.0 million for the three months ended June 30, 2026, compared to $550.8 million for the three months ended June 30, 2025, driven primarily by organic increases in both volume of patient visits and revenue per visit, as described below, and also due to the acquisition of over 240 onsite locations in June 2025. Total VPD volume increased 2.6% to 56,421 for the three months ended June 30, 2026, compared to 55,005 for the three months ended June 30, 2025, primarily due to organic growth. …Concentra Group Holdings Parent, Inc., 10-Q, period ended 2026-06-30, filed 2026-08-06

Read the full passage →